Evidence map›Paper›PMID 31821129›Full record

ArticleJournal of addictive diseases

Assessing factors associated with discharge from opioid agonist therapy due to incarceration in the United States.

Phillip L Marotta, Kristi L Stringer, Amar D Mandavia, Alissa Davis, Leo Beletsky, Tim Hunt, Dawn Goddard-Eckrich, Elwin Wu, Louisa Gilbert, Nabila El-Bassel

Abstract readComparative Study
In one paragraph

Article in Journal of addictive diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Phillip L MarottaDivision of Prevention and Community Research, Department of Psychiatry, The Consultation Center, School of Medicine, Yale University, New Haven, CT, USA.
Kristi L StringerSchool of Social Work, Columbia University, New York, NY, USA.
Amar D MandaviaDepartment of Counseling and Clinical Psychology, Teachers College of Columbia University, New York, NY, USA.
Alissa DavisSchool of Social Work, Columbia University, New York, NY, USA.
Leo BeletskyCenter for the Study of Social Difference, Columbia University, New York, NY, USA.
Tim HuntDivision of Prevention and Community Research, Department of Psychiatry, The Consultation Center, School of Medicine, Yale University, New Haven, CT, USA.
Dawn Goddard-EckrichDivision of Prevention and Community Research, Department of Psychiatry, The Consultation Center, School of Medicine, Yale University, New Haven, CT, USA.
Elwin WuDivision of Prevention and Community Research, Department of Psychiatry, The Consultation Center, School of Medicine, Yale University, New Haven, CT, USA.
Louisa GilbertDivision of Prevention and Community Research, Department of Psychiatry, The Consultation Center, School of Medicine, Yale University, New Haven, CT, USA.
Nabila El-BasselDivision of Prevention and Community Research, Department of Psychiatry, The Consultation Center, School of Medicine, Yale University, New Haven, CT, USA.

Funding

Research Training Program in Substance Use PreventionT32DA019426 · NIDA · YALE UNIVERSITY · PI TAMI P SULLIVAN · 2005 to 2026
$7.5M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
The Lifespan/Brown Criminal Justice Research Program on Substance Use and HIVR25DA037190 · NIDA · MIRIAM HOSPITAL · PI CURT G BECKWITH · 2014 to 2026
$3.5M
A couple-based antiretroviral therapy adherence intervention for people who inject drugs in KazakhstanK01DA044853 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DAVIS, ALISSA · 2018 to 2022
$903k
The impact of criminal justice involvement on retention in a behavioral HIV prevention intervention for couples who use drugs in Almaty, KazakhstanF31DA044794 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI MAROTTA, PHILLIP L · 2018 to 2019
$69k
NIDA NIH HHS F31 DA044794NIDA NIH HHS K01 DA044853NIDA NIH HHS L30 DA049137NIDA NIH HHS R25 DA037190NIDA NIH HHS T32 DA019426NIDA NIH HHS T32 DA037801
6 · The paper itself

Abstract

The following study investigates factors associated with discharge from OAT due to incarceration in a sample of 64,331 discharges in the United States. Multinomial regression investigated the association between demographic factors, prior arrest, referral source (i.e criminal justice agency) intravenous drug use, types of drug used, length of prior treatment and discharge due to incarceration compared to completing treatment or discharge due to other reasons. African Americans, Latinx, and Native Americans were at greater risk of discharge due to incarceration compared to whites. Referral to OAT from criminal justice agencies and self-referral was associated with increased risk of discharge from OAT due to incarceration compared to referral from a health care provider. Substance use of heroin, benzodiazepines, synthetic opioids, cocaine and non-prescription use of methadone were associated with discharge due to incarceration. Risk of discharge due to incarceration was higher for patients who reported intravenous drug use and who reported a co-morbid psychiatric problem. These findings enrich a nascent body of literature on mechanisms associated with attrition from OAT due to incarceration and emphasize the need for programs to divert people with OUD from incarceration to increase engagement and retention in OAT.

Indexed as

AdolescentAdultComorbidityDatabases, FactualDiagnosis, Dual (Psychiatry)FemaleHumansMaleMiddle AgedNarcotic AntagonistsOpioid-Related DisordersPatient Acceptance of Health CarePatient DischargePrisonersRisk FactorsUnited StatesNarcotic AntagonistsattritionincarcerationOpioid Agonist Therapy

Identifiers

PMID31821129
PMCPMC7224404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.